Loading...

AbbVie Inc.

ABBV•NYSE
Healthcare
Drug Manufacturers - General
$198.71
$-2.24(-1.11%)
U.S. Market opens in 15h 23m

AbbVie Inc. (ABBV) Stock Overview

Explore AbbVie Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap351.4B
P/E Ratio83.67
EPS (TTM)$2.38
ROE-3.62%
Fundamental Analysis

AI Price Forecasts

1 Month$225.19
3 Months$221.65
1 Year Target$237.10

ABBV Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of AbbVie Inc. (ABBV) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 34.45, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $237.10.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 83.67 and a market capitalization of 351.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.12%
5-Day Change
-5.23%
1-Month Change
-3.17%
3-Month Change
-9.38%
6-Month Change
-12.85%
Year-to-Date (YTD) Change
-13.04%
1-Year Change
10.16%
3-Year Change
21.09%
5-Year Change
78.37%
All-Time (Max) Change
467.69%

Contact Information

https://www.abbvie.com
847 932 7900
1 North Waukegan Road, North Chicago, IL, 60064-6400

Company Facts

55,000 Employees
IPO DateJan 2, 2013
CountryUS
Actively Trading

Frequently Asked Questions